|1.||Wang, Chong-Zhi: 6 articles (07/2013 - 12/2006)|
|2.||He, Tong-Chuan: 6 articles (07/2013 - 12/2006)|
|3.||Yuan, Chun-Su: 6 articles (07/2013 - 12/2006)|
|4.||Du, Wei: 5 articles (07/2013 - 05/2008)|
|5.||Yan, Qiu: 3 articles (03/2016 - 01/2014)|
|6.||Ha, Young Wan: 3 articles (05/2015 - 04/2009)|
|7.||Kim, Yeong Shik: 3 articles (05/2015 - 04/2009)|
|8.||Joo, Eun Ji: 3 articles (05/2015 - 04/2009)|
|9.||Park, Jeong-Hill: 3 articles (03/2014 - 02/2003)|
|10.||Surh, Young-Joon: 3 articles (03/2014 - 02/2003)|
07/01/2015 - "In conclusion, the results of the present study suggested that ginsenoside Rg3 may potentiate the antitumor effects of radiation therapy in NSCLC by suppressing NF-κB activity and NF-κB-regulated gene products, leading to the inhibition of tumor progression."
03/01/2016 - "Ginsenoside Rg3 is a herbal medicine which inhibits cell proliferation and induces apoptosis in various cancer cells. "
09/15/2015 - "Ginsenoside Rg3 (Rg3), an anti-cancer active ingredient of Panax ginseng, was reported to have anti-oxidative, anti-apoptotic, and cardioprotective properties. "
09/01/2015 - "Ginsenoside Rg3 is one of the main constituents isolated from Panax ginseng, and exhibits cytotoxic effects against cancer cells. "
08/01/2015 - "Ginsenoside Rg3 is an herbal medicine with strong antitumor activity through inhibiting tumor growth and promoting tumor cell death. "
|2.||Lewis Lung Carcinoma
01/01/2009 - "The present study was designed to evaluate the efficacy of low-dose gemcitabine combined with ginsenoside Rg3 on angiogenesis and growth of established Lewis lung carcinoma in mice. "
04/14/2006 - "In the present study, we investigated the efficacy of the combination of low-dose cyclophosphamide and ginsenoside Rg3 for the antiangiogenic effect on Lewis lung carcinoma. "
04/20/2006 - "The aim of this study is to investigate the inhibitory effects of administration of low-dose gemcitabine combined with ginsenoside Rg3 on angiogenesis of mouse Lewis lung carcinoma and the influence of administration on quality of life of mouse. "
08/01/2005 - "[Experimental study on anti-angiogenesis in mice with Lewis lung carcinoma by low-dose of cyclophosphamide combined with ginsenoside Rg3]."
01/01/2009 - "C57L/6 mice implanted with Lewis lung carcinoma were randomized into the control, ginsenoside Rg3, gemcitabine and combination group. "
06/01/2014 - "To determine if the pretreatment of hypoxic human oesophageal carcinoma cell lines (EC109, TE1 and KYSE170) with ginsenoside Rg3 (Rg3) increases their radiosensitivity to X-rays. "
07/01/2003 - "To explore the inhibiting effect of ginsenoside Rg3 on the growth and angiogenesis of orthotopically xenotransplanted human breast infiltrating duct carcinoma in nude mice. "
04/01/2002 - "[Antiangiogenesis of ginsenoside Rg3 in severe combined immunodeficient mice with human ovarian carcinoma]."
08/04/2000 - "In a study of the anti-proliferative activity of ginsenosides using human prostate carcinoma LNCaP cell line, ginsenoside Rg3 displayed growth inhibitory activity. "
07/01/2015 - "The present study demonstrated that ginsenoside Rg3 was able to sensitize A549 and H1299 lung carcinoma cells to γ-radiation and significantly enhance the efficacy of radiation therapy in C57BL/6 mice bearing a Lewis lung carcinoma cell xenograft tumor. "
|4.||Neoplasm Metastasis (Metastasis)
12/28/2015 - "Anti-Metastasis Effects of Ginsenoside Rg3 in B16F10 Cells."
08/05/2008 - "The present study was undertaken to investigate the effect of ginsenoside Rg3 on human ovarian cancer metastasis and the possible mechanism. "
08/05/2008 - "Ginsenoside Rg3 can significantly inhibit the metastasis of ovarian cancer. "
08/05/2008 - "Ginsenoside Rg3 has been found to inhibit several kinds of tumor growth and metastasis. "
08/05/2008 - "Inhibitory effect of ginsenoside Rg3 on ovarian cancer metastasis."
|5.||Colonic Neoplasms (Colon Cancer)
08/01/2015 - "To study the mechanism of the inhibitory effect of ginsenoside Rg3 on colon cancer cell migration. "
08/01/2015 - "Ginsenoside Rg3 inhibits colon cancer cell migration by suppressing nuclear factor kappa B activity."
05/01/2009 - "These results indicate that ginsenoside Rg3 inhibits NF-kappaB, and enhances the susceptibility of colon cancer cells to docetaxel and other chemotherapeutics. "
05/01/2009 - "Inhibition of NF-kappaB by ginsenoside Rg3 enhances the susceptibility of colon cancer cells to docetaxel."
07/01/2012 - "Oral administration of ginsenoside Rg3 significantly inhibited tumor growth and promoted the anti-neoplastic efficacy of cisplatin in mice inoculated with CT-26 colon cancer cells. "
|1.||Heterologous Transplantation (Xenotransplantation)
|3.||Drug Therapy (Chemotherapy)
|5.||Transplantation (Transplant Recipients)